← Back to Analyst Consensus 
CABA Buy
Cabaletta Bio, Inc.
Current Price —
Implied Upside —
Analysts 16
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 9, 2026 (14 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 1, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 14, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| May 15, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| May 4, 2026 | Cantor Fitzgerald | reiterate | Overweight → Overweight | — | 50% |
| Mar 24, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Mar 24, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Oct 31, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $30 | 50% |
| Oct 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Sep 5, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $15 | 50% |
| Aug 14, 2025 | Citigroup | maintain | Buy → Buy | $10 | 54% |
| Aug 8, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $2 | 54% |
| Aug 8, 2025 | Guggenheim | maintain | Buy → Buy | $15 | 52% |
| Jun 11, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| May 16, 2025 | Citigroup | maintain | Buy → Buy | $13 | 54% |
| May 16, 2025 | Guggenheim | maintain | Buy → Buy | $25 | 52% |
| May 15, 2025 | Guggenheim | maintain | Buy → Buy | $25 | 52% |
| Apr 1, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $3 | 54% |
| Apr 1, 2025 | Guggenheim | reiterate | Buy → Buy | $23 | 52% |
| Apr 1, 2025 | UBS | maintain | Buy → Buy | $7 | 54% |
| Apr 1, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $22 | 54% |
| Apr 1, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Feb 18, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Jan 17, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Dec 20, 2024 | Evercore ISI Group | downgrade | Outperform → In-Line | $6 | 58% |
| Dec 19, 2024 | Wells Fargo | downgrade | Overweight → Equal-Weight | $6 | 54% |
| Nov 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Nov 15, 2024 | Wells Fargo | maintain | Overweight → Overweight | $12 | 54% |
| Nov 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Oct 10, 2024 | UBS | initiate | — → Buy | $10 | 54% |
| Sep 17, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Aug 12, 2024 | Wells Fargo | maintain | Overweight → Overweight | $20 | 54% |
| Aug 12, 2024 | Evercore ISI Group | maintain | Outperform → Outperform | $15 | 58% |
| Aug 9, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $25 | 44% |
| Jun 21, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $50 | 50% |
| Jun 17, 2024 | Stifel | maintain | Buy → Buy | $32 | 53% |
| Jun 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| May 24, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| May 16, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Apr 5, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $50 | 50% |
| Apr 4, 2024 | Citigroup | maintain | Buy → Buy | $30 | 54% |
| Mar 22, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $50 | 50% |
| Mar 22, 2024 | Wells Fargo | maintain | Overweight → Overweight | $35 | 54% |
| Mar 22, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $30 | 44% |
| Feb 5, 2024 | Jefferies | initiate | — → Buy | $36 | 52% |
| Nov 29, 2023 | Morgan Stanley | maintain | Overweight → Overweight | $25 | 54% |
| Nov 29, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Nov 15, 2023 | Cantor Fitzgerald | maintain | Overweight → Overweight | $50 | 50% |
| Nov 10, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $25 | 44% |
| Nov 8, 2023 | Morgan Stanley | maintain | Overweight → Overweight | $28 | 54% |
| Oct 24, 2023 | Cantor Fitzgerald | initiate | — → Overweight | $40 | 50% |
Price Target Trend
May 18, 2026 Oct 26, 2026
EPS Estimates
+1y —
0q —
0y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days